NICOLIN, ANGELO NICOLO'
 Distribuzione geografica
Continente #
EU - Europa 3.319
NA - Nord America 1.914
AS - Asia 912
SA - Sud America 46
OC - Oceania 8
AF - Africa 3
Totale 6.202
Nazione #
US - Stati Uniti d'America 1.901
GB - Regno Unito 1.260
SE - Svezia 638
CN - Cina 474
IT - Italia 402
DE - Germania 340
UA - Ucraina 163
TR - Turchia 152
KR - Corea 110
IE - Irlanda 100
RU - Federazione Russa 92
FI - Finlandia 76
EU - Europa 75
IN - India 74
FR - Francia 68
NL - Olanda 64
BE - Belgio 47
VN - Vietnam 42
CO - Colombia 30
HK - Hong Kong 26
PL - Polonia 20
GR - Grecia 18
SG - Singapore 11
CA - Canada 10
DK - Danimarca 8
BR - Brasile 7
ES - Italia 6
ID - Indonesia 6
AU - Australia 5
RO - Romania 5
AR - Argentina 4
CH - Svizzera 4
JP - Giappone 4
TW - Taiwan 4
CL - Cile 3
LT - Lituania 3
MX - Messico 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
CZ - Repubblica Ceca 2
EG - Egitto 2
PH - Filippine 2
AT - Austria 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
NO - Norvegia 1
SA - Arabia Saudita 1
SC - Seychelles 1
UY - Uruguay 1
VE - Venezuela 1
Totale 6.277
Città #
Southend 1.096
Chandler 239
Seattle 199
Milan 189
Princeton 120
Jacksonville 114
Hanover 111
Beijing 108
Wilmington 107
Dublin 100
Ann Arbor 93
Redmond 82
Woodbridge 64
Fairfield 62
Ashburn 61
Nanjing 61
Dearborn 60
Mountain View 58
Sakarya 57
Brussels 47
Frankfurt am Main 46
Serra 46
Des Moines 45
Somerville 40
Houston 38
Boardman 36
Andover 32
New York 32
Bengaluru 29
Bogotá 28
Hong Kong 24
Jinan 24
Shanghai 22
Dong Ket 21
Zhengzhou 20
Cambridge 19
Hebei 19
Warsaw 19
Athens 18
Nanchang 17
Changsha 16
Helsinki 16
Phoenix 16
Shenyang 16
Guangzhou 14
Los Angeles 13
Ningbo 13
Tianjin 13
Bitonto 10
Falls Church 10
Saint Petersburg 10
Auburn Hills 9
San Diego 9
Segrate 9
Berlin 7
Hefei 7
Redwood City 7
Toronto 7
Chengdu 6
Haikou 6
Jiaxing 6
Roxbury 6
Tappahannock 6
Collegno 5
Kunming 5
Lanzhou 5
Leawood 5
Odernheim 5
Seoul 5
Silver Spring 5
Taizhou 5
Xian 5
Yiyuan 5
Chicago 4
Fremont 4
Lakewood 4
Lentini 4
Norwalk 4
Offanengo 4
Pisa 4
Roanoke 4
Rome 4
Turin 4
Verona 4
Córdoba 3
Fuzhou 3
Gessate 3
Guilford 3
Hangzhou 3
London 3
Marcy 3
Mumbai 3
Paris 3
Taiyuan 3
Wuhan 3
Baltimore 2
Birmingham 2
Boston 2
Buffalo 2
Campinas 2
Totale 3.972
Nome #
The 3' untranslated region of human cyclin-dependent kinase 5 regulatory subunit 1 contains regulatory elements affecting transcript stability 204
B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity 201
Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase 194
hnRNPA2/B1 and nELAV proteins bind to a specific U-rich element in CDK5R1 3'-UTR and oppositely regulate its expression 178
MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel 153
miR-103 and miR-107 are involved in the regulation of CDK5R1/p35 expression 150
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt 148
Identification of TINO : a new evolutionarily conserved BCL-2 AU-rich element RNA-binding protein 145
Inhibition of tumor cell proliferation by linear polyunsaturated aldehydes 144
Functional study of transcription cis-regulatory elements predicted in the CDK5R1 3’UTR 144
Assimilation of LDL by experimental tumours in mice 140
mTOR: a protein kinase switching between life and death 135
Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia 128
Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger 127
[The pharmacologic activity of 1(2-(p-chloro-alpha-phenylbenzyloxy)ethyl)piperidine (cloperastine)] 127
Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light 127
Identification of a potential regulatory element forming a hairpin structure within the 3’UTR of CDK5R1 125
zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia 124
The human CDK5R1 3'UTR contains distinct subregions affecting transcript stability 123
ANTISENSE OLIGONUCLEOTIDE BLOCKS PROGESTERONE-INDUCED LORDOSIS BEHAVIOR IN OVARIECTOMIZED RATS 121
Alterazioni antigeniche indotte da dimetil-triazeno-carbossamide (DTIC) nella leucemia L1210. Attivita' citotossica in vitro di splenociti immuni. 120
Apoptosis is associated with modifications of bcl-2 mRNA AU-binding proteins 117
Antisense oligonucleotide drug design 116
Post-transcriptional regulation of gene expression by degradation of messenger RNAs 116
Increased bcl2 expression by antisense oligoribonucleotides targeting the adenine-uridine-rich element motif 116
A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis 114
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines 113
Stabilization of cellular mRNAs and up-regulation of proteins by oligoribonucleotides homologous to the Bcl2 adenine-uridine rich element motif 112
Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors 110
AUF1 Is a bcl-2 A + U-rich element-binding protein involved in bcl-2 mRNA destabilization during apoptosis 108
BCL-2 regulation targeting the AU-rich domain 108
Immunopharmacology studies on photosensitizers used in photodynamic therapy (PDT) 108
Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia 106
Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase 102
The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides 102
In vitro hematoporphyrin (Hpd) inhibitory effects on some immunological assays 100
Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles 99
Haematoporphyrin-treated murine lymphocytes: in vitro inhibition of DNA synthesis and light-mediated inactivation of cells responsible for GVHR 98
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme 94
Hematoporphyrin derivative photoradiation therapy in murine solid tumors 94
Effect of photodynamic therapy with photoactivated aluminum disulfonated phthalocyanine on antitumor immune response 93
In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice 90
Oligonucleotide degradation contributes to resistance to antisense compounds 89
Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors 89
Humoral and cellular immunoresponse of mice treated with pyrazole-carboxamide-4-amino (PCA). 89
Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells 87
Impact of targeting the adenine- and uracil-rich element of bcl-2 mRNA with oligoribonucleotides on apoptosis, cell cycle, and neuronal differentiation in SHSY-5Y cells 87
Wine and tumors: study of resveratrol 86
RNA targeting in cancer cells 86
Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines 86
Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect 85
Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody 85
Monoclonal antibody to L1210 leukemia: characterization and therapeutic activity 85
Photoradiation therapy with Hpd and laser light 77
Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line 71
PLASMA RETINOL LEVELS AND SIDE-EFFECTS FOLLOWING HIGH-DOSE RETINYL ACETATE IN BREAST-CANCER PATIENTS 68
Synthetic antisense oligonucleotides: Principles and antileukemic activity 64
Time-resolved fluorescence spectroscopy of hematoporphyrin derivatives and disulfonated aluminum phthalocyanine incorporated in vivo in a murine ascitic tumor 63
Immunofarmacologia dei nuovi composti fotosensibilizzanti nella PDT dei tumori 54
Totale 6.625
Categoria #
all - tutte 12.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019158 0 0 0 0 0 0 0 13 68 17 26 34
2019/2020723 93 12 39 24 53 82 64 35 138 129 43 11
2020/2021918 103 41 108 12 108 43 30 32 87 51 228 75
2021/2022778 66 27 32 71 70 60 72 34 37 78 82 149
2022/2023967 128 116 92 116 90 210 20 61 82 14 23 15
2023/2024331 23 49 33 38 133 30 5 20 0 0 0 0
Totale 6.625